Article
Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity.
Journal of human genetics - 1 Jun 2013
Hertz Daniel L, McLeod Howard L
Abstract excerpt
Cancer treatment is complicated because of a multitude of treatment options and little patient-specific information to help clinicians choose appropriate therapy. There are two genomes relevant in cancer treatment: the tumor (somatic) and the patient (germline). Together, these two genomes dictate treatment outcome through four processes: the somatic genome primarily determines tumor prognosis and response while...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
